2013, Number 2
Hyperglycemia, prognosis marker of adverse events in heart attack
Language: Spanish
References: 16
Page: 72-78
PDF size: 368.45 Kb.
ABSTRACT
Introduction: Hyperglycemia on admission in patient with acute coronary syndrome is common, considered bad marker of clinical evolution and death.Objective: To value the use of admission glycemia like prognosis factor of adverse events in patient with heart attack.
Method: Descriptive study and longitudinal prospective. 246 patients were included with heart attack admitted in Cienfuegos hospital and their evolution was continued during 30 days. It was determined as point of a very best cut for the mortality at admission glycemia ≥ 7,1mmol/l by means of the curve ROC and one carries out analysis logistics regression to identify independent predictors of death.
Results: The patients with glycemia ≥ 7,1mmol/l prevailed the diabetes, tachycardia, killip≥II, inferior localization, small ejection fraction and bigger incidence of adverse events (60% versus 2%, p=0,000) as heart failure(30% versus 15%; p = 0,001), malign ventricular arrhythmias (23% versus 4%; p = 0,000) and death(15% versus 3%; p = 0,001), with smaller survival regarding the patients with glycemia ‹7,1mmol/l(85,5% in contrast with 96,6%). Age and ejection fraction were independent predictors of death in the multivariate analysis.
Conclusions: In patient with myocardial infarction the hyperglycemia to the entrance, with a cut point ≥7,1mmol/l, predicts a short term increment of adverse events, although it was not independent predictor of death.
REFERENCES
Cid-Álvarez B, Gude F, Cadarso-Suárez C, González-Babarro E, Rodríguez-Álvarez MX, García-Acuña JM, et al. Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coro-nary syndrome: nonlinearity of hazard ratios and time-dependent comparison. Am Heart J. 2009; 158:889-97. Dis-ponible en: http://www.ahjonline.com/article/S0002-8703(09)00780-7/abstract
Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, and Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008; 117:1818-27. Dis-ponible en: http://www.ncbi.nlm.nih.gov/pubmed/18299511?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus
Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syn-drome. A scientific statement from the American Heart Asso-ciation Diabetes Committee of the Council on Nutrition, Phys-ical Activity, and Metabolism. Circulation. 2008; 117:1010-9. Disponible en: http://circ.ahajournals.org/content/vol117/issue12/
Monteiro S, Gonçalves F, Monteiro P, Freitas M, Pro-vidência L. Magnitud de la variación de la glucemia: ¿un nue-vo instrumento para la evaluación del riesgo en el síndrome coronario agudo? Rev Esp Cardiol. 2009; 62:1099-108. Dis-ponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=45&ident=13141787
Macín S, Perna E, Coronel M, Kriskovich J, Bayol P, Fran-ciosi V, et al. Influencia de la concentración de glucemia en el momento del ingreso en la evolución a largo plazo de los pa-cientes con síndrome coronario agudo. Rev Esp Cardiol. [In-ternet]. 2006; 59h12min-75. Disponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13004158
Vivas D, García-Rubira JC, González-Ferrer JJ, Núñez-Gil I, Del Prado N, Fernández-Ortiz A, et al. Valor pronóstico de la primera glucemia en ayunas en comparación con la gluce-mia al ingreso en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2008:61:458-64. Disponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13006208
Panduranga P, Sulaiman K, Al-Lawati J, Al-Zakwani I. Rela-tionship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in Oman. Heart Views. 2011; 12:12-7. Disponible en: http://dx.crossref.org/10.4103%2F1995-705X.81554
Sanjuán R, Núñez J, Blasco ML, Miñana G, Martínez H, Carbonell N, et al. Implicaciones pronósticas de la hiperglu-cemia de estrés en el infarto agudo de miocardio con eleva-ción del ST. Estudio observacional prospectivo. Rev Esp Cardiol. 2011; 64:201-7. Disponible en: http://www.revespcardiol.org/sites/default/files/elsevier/pdf/25/25v64n03a90000662pdf001.pdf
Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short- term and 6-month mortality in ST-segment elevation and non-ST- segment elevation acute co-ronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med. 2009; 169:402-9. Disponible en: www.ncbi.nlm.nih.gov/pubmed?term=%22Sinnaeve%20PR%22%5BAuthor%5D